98
Participants
Start Date
April 26, 2019
Primary Completion Date
April 5, 2024
Study Completion Date
April 5, 2024
GT005
GT005 is a recombinant, non-replicating AAV2 expressing human complement factor I (CFI). GT005 was administered as a single time subretinal injection into the study eye of subjects allocated to one of the two GT005 doses.
Sydney Hospital and Sydney Eye Hospital, Sydney
Columbia University Medical Center, New York
Centre Paradis Monticelli, Marseille
Hospital La Arruzafa, Córdoba
Retina Associates of Western New York, Rochester
Erie Retinal Surgery, INC, Erie
Mid Atlantic Retina, Philadelphia
CHU Hôpital F. Mitterrand, Dijon
The Retina Care Center, Baltimore
Universitaetsklinikum Schleswig-Holstein Campus Lübeck, Lübeck
West Virginia University, Morgantown
Clinica Baviera, Madrid
Southeast Retina Center, Augusta
Clinica Universidad de Navarra - Pamplona, Pamplona
VitreoRetinal Associates, P.A., Gainesville
Bascom Palmer Eye Institute, Miami
Retina Vitreous Associates of Florida, St. Petersburg
Southeastern Retina Associates, PC, Knoxville
Charles Retina Institute, Memphis
Internationale Innovative Ophthalmochirurgie, Düsseldorf
CHU de Nantes - Hôtel-Dieu, Nantes
Cleveland Clinic, Cleveland
Cincinnati Eye Institute, Cincinnati
Clinica Oftalvist Valencia, Valencia
Midwest Eye Institute Northside, Indianapolis
St. Franziskus-Hospital, Münster
Wolfe Eye Clinic, West Des Moines
Universitaetsklinikum Bonn, Bonn
VitreoRetinal Surgery, PLLC, Minneapolis
University Retina Macula Associates PC, Lemont
Universitatsklinikum Tübingen, Tübingen
Texas Retina Associates, Dallas
Retina Consultants of Houston-TMC, Bellaire
Retinal Consultants of San Antonio, San Antonio
Austin Research Center for Retina, PLLC, Austin
Retinal Research Institute (retina consultants of AZ), Phoenix
Vision Research Center Eye Associates of New Mexico, Albuquerque
Sierra Eye Associates, Reno
Retina Consultants San Diego, Poway
Retina Associates of Southern California, Huntington Beach
Byers Eye Institute at Stanford, Palo Alto
Casey Eye Institute, Portland
Oregon Retina, Eugene
Ophthalmic Consultants of Boston (OCB), Boston
Department of Ophthalmology UW Medicine, Seattle
The University of Melbourne - The Centre for Eye Research Australia (CERA), Melbourne E.
Stichting Radboud Universitair Medisch Centrum, Nijmegen
Oftalmika Spolka z ograniczona odpowiedzialnoscia, Bydgoszcz
Hospital Universitari General de Catalunya, Sant Cugat del Vallès
Bristol Eye Hospital, Bristol
St.Paul's Eye Unit, Liverpool
Moorfields Eye Hospital - NHS Foundation Trust, London
The Retina Clinic London, London
Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield
Sunderland Eye Infirmary, Sunderland
Lead Sponsor
Collaborators (1)
Novartis Pharmaceuticals
INDUSTRY
Gyroscope Therapeutics Limited
INDUSTRY